window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 13, 2025

  • News
  • About Us
Contact Us

drug discovery

  • Artificial Intelligence,Drug Development,Market Access & Commercialization,Partnerships & Funding

    Optibrium secures multi-million-pound funding to power global AI drug discovery expansion

    Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

    July 8, 2025
  • Artificial Intelligence,Drug Development,Technology and platforms

    Optibrium and TalTech launch EU-funded PhD to advance sustainable drug discovery

    Partnership aims to boost predictive metabolism models using machine learning [...]

    July 2, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding

    Oxeltis and MFI join forces as $12.8 BN in silico drug discovery market accelerates

    Contract research firm Oxeltis and computational chemistry company Molecular Forecaster [...]

    June 30, 2025
  • Drug Delivery & Formulation,Drug Development,Precision medicine

    UK poised to lead in functional genomics, BIA says

    The BioIndustry Association (BIA) has released a new explainer highlighting [...]

    June 13, 2025
  • Biologics & Biosimilars,Precision medicine

    Enhanced Genomics appoints biotech veteran Dietrich Stephan as chair to drive next-gen target discovery

    Enhanced Genomics has appointed leading biotechnology entrepreneur Dietrich Stephan as [...]

    June 12, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Partnerships & Funding,Technology and platforms

    Sofinnova Partners and NVIDIA join forces to boost European AI in life sciences

    Sofinnova Partners has announced a new collaboration with NVIDIA to [...]

    June 12, 2025
  • Biologics & Biosimilars,Drug Development,Technology and platforms

    Revolutionizing omics and biopharma: Thermo Fisher Scientific’s latest instruments debut at ASMS 2025

    Thermo Fisher Scientific has unveiled a new suite of analytical [...]

    June 2, 2025
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025
  • Artificial Intelligence,Drug Development,Movers & Shakers

    Ochre Bio appoints pharma veteran Elaine Sullivan as senior independent director

    RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]

    May 29, 2025
  • Drug Development,Movers & Shakers

    Domainex appoints Hayley French as CEO to drive next phase of growth

    Contract research organisation Domainex has named Hayley French as its [...]

    May 29, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno taps global CRO for next big step in pulmonary hypertension drug trial
    Categories: Clinical Trials, Drug Development, Rare Diseases
  • Eleva doses first volunteers with new therapy targeting rare kidney disease
    Categories: Biologics & Biosimilars, Clinical Trials, Drug Development, Rare Diseases
  • First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track
    Categories: Cell & Gene Therapy, Clinical Trials, Rare Diseases, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top